Table G-13Characteristics of placebo-controlled trials of other second-generation antidepressants omitted from main analyses because of high risk of bias

TrialArm
Dose mg/Day (N)		Duration (Weeks)Population Trauma TypeBaseline PTSD SeverityaMean
Age (Y)		% Female
% Nonwhite
Davis et al., 2004205Nefazodone
(100 to 600) (27)
Placebo (15)		12Male and female
Mixed		81.0 to 83.2542.4

46

Abbreviations: mg = milligram; N =number; PTSD = posttraumatic stress disorder; y = year.

From: Appendix G, Documentation of Trials Rated High Risk of Bias

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 207.
Forman-Hoffman V, Middleton JC, Feltner C, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.